Development of intermediary compounds for 4th generation antibiotics in progress.

Published: 1999-10-11 15:03:00

Updated: 1999-10-11 15:03:00

Daewoong Chemical (President: Mr. Moon Soon-ku) has succeeded in developing the key intermediary compounds (DW-1150) for the new 4th generation of Phenem and Carbaphenem antibiotics,

The core technology of the intermediary materials for the 4th generation antibiotic production has been pred...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK